Osalmid

Overview

Osalmid is a ribonucleotide reductase small subunit M2 ( RRM2 ) targeting compound; suppresses ribonucleotide reductase activity with an IC 50 of 8.23 μM.

Application

Products | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Viral Infection | Products > Signaling Pathways > Others | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Environmental Pollutants | Products > Signaling Pathways > HBV

Product Information

• Catalog No.: HY-B2116
• CAS No.: 526-18-1
• Molecular Formula: C13H11NO3
• Molecular Weight: 229.23
• Purity: 99.91%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (10.91 mM); Clear solution
• Availability: In-stock

Source

Original product source